Prospective study of urinary prostaglandin E2 metabolite and lung cancer risk

被引：1
|
作者：
Cai, Qiuyin
Gao, Yu-Tang
Wen, Wanqing
Milne, Ginger L.
Yang, Gong
Ji, Bu-Tian
Rothman, Nathaniel
Li, Hong-Lan
Shu, Xiao-Ou
Chow, Wong-Ho
Zheng, Wei
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-2790
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2790
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk
    Cui, Yong
    Shu, Xiao-Ou
    Li, Hong-Lan
    Yang, Gong
    Wen, Wanqing
    Gao, Yu-Tang
    Cai, Qiuyin
    Rothman, Nathaniel
    Yin, Hui-Yong
    Lan, Qing
    Xiang, Yong-Bing
    Zheng, Wei
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (12) : 2423 - 2429
  • [2] Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk
    Cai, Qiuyin
    Gao, Yu-Tang
    Chow, Wong-Ho
    Shu, Xiao-Ou
    Yang, Gong
    Ji, Bu-Tian
    Wen, Wanqing
    Rothman, Nathaniel
    Li, Hong-Lan
    Morrow, Jason D.
    Zheng, Wei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (31) : 5010 - 5016
  • [3] Urinary Prostaglandin E2 Metabolite and Breast Cancer Risk
    Cui, Yong
    Shu, Xiao-Ou
    Gao, Yu-Tang
    Cai, Qiuyin
    Ji, Bu-Tian
    Li, Hong-Lan
    Rothman, Nathaniel
    Wu, Jie
    Yang, Gong
    Xiang, Yong-Bing
    Zheng, Wei
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (12) : 2866 - 2873
  • [4] A prospective study of urinary prostaglandin E2 metabolite, Helicobacter pylori antibodies, and gastric cancer risk
    Wang, Tianyi
    Cai, Hui
    Zheng, Wei
    Michel, Angelika
    Pawlita, Michael
    Milne, Ginger
    Xiang, Yong-Bing
    Gao, Yu-Tang
    Li, Hong-Lan
    Rothman, Nathaniel
    Lan, Qing
    Shu, Xiao-Ou
    Epplein, Meira
    [J]. CANCER RESEARCH, 2017, 77
  • [5] A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk
    Wang, Tianyi
    Cai, Hui
    Zheng, Wei
    Michel, Angelika
    Pawlita, Michael
    Milne, Ginger
    Xiang, Yong-Bing
    Gao, Yu-Tang
    Li, Hong-Lan
    Rothman, Nathaniel
    Lan, Qing
    Shu, Xiao-Ou
    Epplein, Meira
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 64 (10) : 1380 - 1386
  • [6] Prospective study of urinary prostaglandin E2 and prostacyclin metabolites and lung cancer risk.
    Cai, Qiuyin
    Xiang, Yong-Bing
    Wen, Wanqing
    Milne, Ginger L.
    Li, Hong-Lan
    Wu, Jie
    Yang, Gong
    Gao, Jing
    Dorjgochoo, Tsogzolmaa
    Gao, Yu-Tang
    Zheng, Wei
    Shu, Xiao Ou
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [7] Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk (vol 24, pg 5010, 2006)
    Cai
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 2149 - 2149
  • [8] Urinary Prostaglandin E2 Metabolite and Risk for Colorectal Adenoma
    Shrubsole, Martha J.
    Cai, Qiuyin
    Wen, Wanqing
    Milne, Ginger
    Smalley, Walter E.
    Chen, Zhi
    Ness, Reid M.
    Zheng, Wei
    [J]. CANCER PREVENTION RESEARCH, 2012, 5 (02) : 336 - 342
  • [9] Urinary Prostaglandin E2 Metabolite and Gastric Cancer Risk in the Shanghai Women's Health Study
    Dong, Linda M.
    Shu, Xiao-Ou
    Gao, Yu-Tang
    Milne, Ginger
    Ji, Bu-Tian
    Yang, Gong
    Li, Hong-Lan
    Rothman, Nathaniel
    Zheng, Wei
    Chow, Wong-Ho
    Abnet, Christian C.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (11) : 3075 - 3078
  • [10] Association between Urinary Prostaglandin E2 Metabolite and Breast Cancer Risk: A Prospective, Case-Cohort Study of Postmenopausal Women
    Kim, Sangmi
    Taylor, Jack A.
    Milne, Ginger L.
    Sandler, Dale P.
    [J]. CANCER PREVENTION RESEARCH, 2013, 6 (06) : 511 - 518
12345